Understanding hyperphagia: the urgency to manage and treat

Thursday, 21 March 2024, Webinar: Online

About 
the event

Watch this second promotional Rhythm-organised webinar of the 'Understanding hyperphagia' series to hear Professor Carel Le Roux, Professor Martin Wabitsch and Dr Metin Cetiner discuss the importance of early treatment of hyperphagia and and the impact of setmelanotide in rare MC4R pathway diseases

KEY TOPICS:

  • The MC4R pathway: function, impairments and impact on hyperphagia
  • Real-life burden of patients and caregivers, and the urgency to treat hyperphagia
  • The management of hyperphagia and the impact of setmelanotide  in rare MC4R pathway diseases
  • Setmelanotide practicalities in Bardet-Biedl syndrome: real-life treatment of patients with hyperphagia, and early-onset severe obesity

Professor Martin Wabitsch discusses the MC4R pathway, it's function and disruption, hyperphagia and the impact of Setmelanotide on MC4R pathway diseases

The management of hyperphagia and the impact of setmelanotide in rare MC4R pathway diseases

Prof. Martin Wabitsch

Please login or signup to unlock the videos

Rhythm Pharmaceuticals is leveraging a IQVIA's Healthcare Professional Authentication solution to identify your eligibility to access this video content. If you already have an IQVIA account using it with other healthcare providers, please click 'Login' otherwise click 'Signup'.

LoginSignup

Speakers:

Photo of Prof. Carel Le Roux

Prof Carel Le Roux

(Ireland)

Prof. Martin Wabitsch

(Germany)

Dr Metin Cetiner, MD, PhD

(Germany)

If you are interested in hearing more about future Rhythm organised events, click here to register your interest.


This meeting was organised and funded by Rhythm Pharmaceuticals and is intended for HCPs only and includes promotional content on setmelanotide.